You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 60429-0222


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 60429-0222

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
TERBINAFINE HCL 250MG TAB Golden State Medical Supply, Inc. 60429-0222-30 30 4.05 0.13500 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for Drug NDC: 60429-0222

Introduction to NDC 60429-0222

The drug with the National Drug Code (NDC) 60429-0222 is Terbinafine Hydrochloride, a medication used to treat fungal infections. It is manufactured and distributed by Golden State Medical Supply, Inc.[1].

Current Market Context

Pharmaceutical Market Growth

The US pharmaceutical market, which includes drugs like Terbinafine Hydrochloride, is projected to grow significantly from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].

Generic Drugs and Biosimilars

The market is heavily influenced by the increasing approvals and competition from generic drugs and biosimilars. This trend is expected to continue, with 37% of life sciences executives viewing competition from generics and biosimilars as a top trend in 2025[3].

Pricing and Access

Pricing Trends

Pricing and access to drugs are significant issues in the life sciences industry. Nearly half of the C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025. This includes the impact of generic drugs, which often reduce the market price of branded medications[3].

NDC 60429-0222 Pricing

As a generic medication, Terbinafine Hydrochloride (NDC 60429-0222) is generally priced lower than its branded counterparts. However, specific pricing details for this NDC are not publicly available in the provided sources. Typically, generic drug prices are influenced by market competition, production costs, and regulatory factors.

Regulatory and Market Dynamics

Patent Expirations

The biopharma industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products, which could impact the pricing and availability of certain drugs. However, since Terbinafine Hydrochloride is already a generic medication, it is less likely to be directly affected by patent expirations[3].

Regulatory Environment

Regulatory processes and pricing policies can significantly impact the market price of drugs. For instance, changes in Medicaid and Medicare reimbursement rates or state-specific pricing regulations can influence the overall market dynamics[2].

Technological Advancements

Role of AI in Drug Discovery

The increasing adoption of AI-based tools in drug discovery and development is expected to boost operational efficiencies and drive innovation in the pharmaceutical industry. While this may not directly impact the pricing of existing generic drugs like Terbinafine Hydrochloride, it could lead to more efficient production processes and potentially lower costs in the long term[4].

Price Projections

Generic Drug Pricing

Given the competitive nature of the generic drug market, prices for Terbinafine Hydrochloride (NDC 60429-0222) are likely to remain stable or decrease slightly over the next few years. This is due to the ongoing competition from other generic manufacturers and the overall trend of decreasing prices for generic medications.

Market Forces

The growth in pharmaceutical production capacity and the increasing approvals of generic drugs are expected to keep prices in check. Here is a hypothetical price projection based on these trends:

  • Short-term (2025-2027): Prices may remain stable or see a minor decrease due to continued competition in the generic market.
  • Medium-term (2028-2030): As the market continues to grow and more generic options become available, prices could decrease further, reflecting the increased competition and market pressures.

Key Takeaways

  • The US pharmaceutical market is expected to grow significantly, driven by factors such as increased R&D investments and the adoption of AI-based tools.
  • Generic drugs like Terbinafine Hydrochloride (NDC 60429-0222) are likely to see stable or decreasing prices due to market competition.
  • Regulatory and technological advancements will continue to shape the pricing and availability of pharmaceuticals.

FAQs

Q: What is the current market trend for generic drugs like Terbinafine Hydrochloride? A: The market trend for generic drugs is characterized by increasing competition and stable or decreasing prices due to the availability of multiple generic options.

Q: How does the adoption of AI in drug discovery impact generic drug prices? A: While AI adoption primarily affects new drug development, it can lead to more efficient production processes, potentially reducing costs for generic drugs in the long term.

Q: What are the key factors influencing the pricing of Terbinafine Hydrochloride? A: Key factors include market competition, production costs, regulatory policies, and the overall growth of the pharmaceutical market.

Q: How do patent expirations affect the pricing of generic drugs? A: Patent expirations generally lead to the introduction of more generic options, increasing competition and potentially lowering prices.

Q: What is the projected growth rate of the US pharmaceutical market? A: The US pharmaceutical market is projected to grow at a CAGR of 5.36% from 2022 to 2030[4].

Sources

  1. Find-A-Code: Golden State Medical Supply - NDC products.
  2. Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.